Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple "MIRAGE"?

Davide Giovanni Bosetti; Antonio Angrisani; Francesco Mosè Castronovo; Gianfranco Angelo Pesce; Thomas Zilli

doi:10.21037/tcr-23-611

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple "MIRAGE"?

Transl Cancer Res. 2023 Oct 31;12(10):2454-2457. doi: 10.21037/tcr-23-611. Epub 2023 Oct 7.

Authors

Davide Giovanni Bosetti¹, Antonio Angrisani¹, Francesco Mosè Castronovo¹, Gianfranco Angelo Pesce¹, Thomas Zilli^{1

2

3}

Affiliations

¹ Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
² Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Lugano, Switzerland.
³ Faculty of Medicine, University of Geneva, Geneva, Switzerland.

No abstract available

Keywords: Prostate cancer (PCa); magnetic resonance imaging-guided radiotherapy (MRI-guided radiotherapy); stereotactic body radiation therapy (SBRT); toxicity.

Publication types

Editorial
Comment